Natrox

NATROX® Wound Care | Continuous Topical Oxygen Therapy

Business Model
B2B
Total Funding
$33.0M
Last Round
$33.0M Series CDec 2024
Rounds
2

About

NATROX Wound Care, a brand of Inotec AMD Ltd, develops wearable medical devices that deliver continuous topical oxygen therapy to help heal chronic and hard-to-heal wounds. The NATROX O2 system uses the natural healing properties of oxygen to stimulate wound healing without applying pressure or chemicals to the skin. The company serves clinicians and patients treating diabetic foot ulcers, venous leg ulcers, and other chronic wounds, and its mission is to transform quality of life for anyone living with a hard-to-heal wound.

Summary

Natrox is a Healthcare company. It has raised $33.0M in total across 2 rounds, most recently a $33.0M Series C round in Dec 2024. Investors include Amadeus Capital Partners and Wealth Club.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CDec 2024
$33.0M

Sign up to see all 2 rounds

Venture Round through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Natrox on Indexed.vc
<a href="https://indexed.vc/companies/natrox"><img src="https://indexed.vc/api/badge/company/natrox" alt="Natrox on Indexed.vc" width="260" height="76" /></a>